These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21549367)

  • 21. Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS.
    Capuzzo M; La Marca A
    Front Endocrinol (Lausanne); 2020; 11():616766. PubMed ID: 33633686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by abnormally enhanced promoter activity in polycystic ovary syndrome granulosa cells.
    Li Y; Wei LN; Liang XY
    Fertil Steril; 2011 Jun; 95(7):2354-8, 2358.e1. PubMed ID: 21514585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of anti-Mullerian hormone: performances of a new ultrasensitive immunoassay.
    Gruson D; Homsak E
    Clin Biochem; 2015 Apr; 48(6):453-5. PubMed ID: 25575745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two immunoassays for antimullerian hormone measurement: analytical and clinical performances].
    Taieb J; Belville C; Coussieu C; Guibourdenche J; Picard JY; Di clemente N
    Ann Biol Clin (Paris); 2008; 66(5):537-47. PubMed ID: 18957343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimüllerian hormone: a marker for prediction of ovarian function and polycystic ovary syndrome.
    Seow KM; Wang PH
    J Chin Med Assoc; 2012 Mar; 75(3):93-4. PubMed ID: 22440264
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum Müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome.
    Siow Y; Kives S; Hertweck P; Perlman S; Fallat ME
    Fertil Steril; 2005 Oct; 84(4):938-44. PubMed ID: 16213847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B; Ozkan S; Bodur H
    J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model.
    Park JH; Choi TS
    Biochem Biophys Res Commun; 2012 Nov; 427(4):701-4. PubMed ID: 23022527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study.
    Almog B; Shehata F; Suissa S; Holzer H; Shalom-Paz E; La Marca A; Muttukrishna S; Blazar A; Hackett R; Nelson SM; Cunha-Filho JS; Eldar-Geva T; Margalioth EJ; Raine-Fenning N; Jayaprakasan K; McIlveen M; Wunder D; Freour T; Nardo LG; Balasch J; Peñarrubia J; Smeenk J; Gnoth C; Godehardt E; Lee TH; Lee MS; Levin I; Gamzu R; Tulandi T
    Fertil Steril; 2011 Jun; 95(7):2359-63, 2363.e1. PubMed ID: 21457958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Müllerian hormone - is it a clinically useful test?
    Fenton A; Panay N
    Climacteric; 2013 Feb; 16(1):1-2. PubMed ID: 23320765
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum anti-Müllerian hormone and polycystic ovary syndrome: a matter of methods?
    Parco S; Novelli C; Princi T
    Minerva Pediatr; 2014 Aug; 66(4):335-6. PubMed ID: 25198571
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndrome.
    McCullough K; Ledger W
    Womens Health (Lond); 2016 Jun; 12(3):263-5. PubMed ID: 27167142
    [No Abstract]   [Full Text] [Related]  

  • 35. Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?
    Huang S; Qiao J; Li R; Wang L; Li M
    Fertil Steril; 2010 Jun; 94(1):205-10. PubMed ID: 19368908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS).
    Wassell J; Michail M; Soliman N; Wardle PG
    Clin Lab; 2011; 57(1-2):95-8. PubMed ID: 21391472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone.
    Capuzzo M; Donno V; La Marca A
    Minerva Endocrinol; 2020 Dec; 45(4):376-380. PubMed ID: 33478206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Mullerian hormone and breast cancer risk-is the correlation possibly associated with the PCOS?
    Blumenfeld Z
    Int J Cancer; 2019 Jan; 144(1):211. PubMed ID: 29987838
    [No Abstract]   [Full Text] [Related]  

  • 39. Is polycystic ovary syndrome an exception for reproductive aging?
    Tehrani FR; Solaymani-Dodaran M; Hedayati M; Azizi F
    Hum Reprod; 2010 Jul; 25(7):1775-81. PubMed ID: 20435693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.